This result suggests that VLPs-M8 may represent a therapeutic treatment for acute viral infections and corroborates previous studies demonstrating the ability of M8 to inhibit ongoing dengue and chikungunya virus replication in vitro and in vivo, respectively (Olagnier et al., 2014; Chiang et al., 2015). Here, PRNT is linked to viral infectious disease.